Compare Immunovant Inc. Common Stock (IMVT) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.47 (market cap $6.25B), while iShares 1 3 Year Treasury Bond ETF trades at $81.2 (market cap $26.68B). The key difference: iShares 1 3 Year Treasury Bond ETF is far larger — about 4.3× Immunovant Inc. Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and iShares 1 3 Year Treasury Bond ETF for 63 Days on average.
| IMVT | SHY | |
|---|---|---|
Market Cap | $6.25B | $26.68B |
Volume | 1,755,411 | 4,077,691 |
Sector | Health | Fixed Income |
52-Week High | $44.96 | $83.18 |
52-Week Low | $17.03 | $81.05 |
Typical Hold Time | 1 Days | 63 Days |
Enterprise Value | $5.35B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SHY, a US stock, trades at $81.20 with minimal daily movement (+0.05%). The technical outlook is bearish, with moving averages signaling downward pressure and key indicators like the ADX_12 at 50.39 suggesting a strong trend. Recent corporate actions include scheduled dividends through late 2026, though financial ratios (P/E, P/S, etc.) are unavailable in the current snapshot. Market sentiment is influenced by broader bond market volatility, with news highlighting rising Treasury yields and geopolitical tensions impacting inflation expectations.
The outlook for SHY is cautious amid a bearish technical setup and macroeconomic headwinds, including higher interest rates and inflation concerns. Opportunities may arise from its dividend payments, but risks include sustained bond market sell-offs and economic uncertainty. Investors should weigh the stock's stability against potential volatility from external factors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
